Middle East & Africa Mirna Sequencing And Assay Market Size & Outlook
Middle East & Africa mirna sequencing and assay market, 2018-2030 (US$M)
Related Markets
MEA mirna sequencing and assay market highlights
- The MEA mirna sequencing and assay market generated a revenue of USD 8.8 million in 2023.
- The market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 8.8 million |
| Market revenue in 2030 | USD 15.6 million |
| Growth rate | 8.5% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.6% of the global mirna sequencing and assay market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 227.1 million by 2030.
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MiRNA Sequencing And Assay Market Scope
MiRNA Sequencing And Assay Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa mirna sequencing and assay market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.68% in 2023. Horizon Databook has segmented the Middle East & Africa mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East & Africa has a high prevalence of chronic disease with an increasing disease burden. The increase in disposable income in the Middle Eastern & African countries has resulted in infrastructure development in the area.
It is expected that further increases in awareness and disposable income across this region may bridge the gap and help provide the sequencing industry with added business, investments, & partnerships.
Furthermore, South Africa is dominating the miRNA sequencing and assay market owing to advancements in infrastructure with respect to the biotechnology industry and laboratories that offer sequencing services in the region.
Reasons to subscribe to Middle East & Africa mirna sequencing and assay market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa mirna sequencing and assay market databook
-
Our clientele includes a mix of mirna sequencing and assay market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa mirna sequencing and assay market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA mirna sequencing and assay market size, by country, 2018-2030 (US$M)
Middle East & Africa MiRNA Sequencing And Assay Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
